India Malaria Diagnostics Market Expected to Hit US$ 81.6 Mn by 2032, States Persistence Market Research

The India malaria diagnostics market is poised for moderate but consistent growth, expected to expand from US$ 61.6 million in 2025 to US$ 81.6 million by 2032. This equates to a projected compound annual growth rate (CAGR) of 4.1% during the forecast period. The market has historically witnessed a growth rate of 3.3% from 2019 to 2024, indicating a stable and sustained demand for malaria diagnostic solutions.

Several underlying trends are influencing market trajectory. These include increasing collaborations between government agencies, private diagnostic providers, and international institutions such as WHO and the Global Fund. Government-backed initiatives like the National Strategic Plan for Malaria Elimination have led to the wider deployment of diagnostic technologies across endemic and remote regions. Simultaneously, technological advancements-particularly in molecular diagnostics-are redefining the detection of low-parasitemia and asymptomatic infections in both high- and low-endemic zones.

Get a Sample Copy of Research Report (Use Corporate Mail id for Quick Response): https://www.persistencemarketresearch.com/samples/35426

Key Industry Highlights

India's malaria diagnostics landscape is evolving rapidly with a clear shift toward precision-based detection. The rise of RT-qPCR and conventional PCR in urban diagnostic labs signals a technological leap beyond traditional microscopy. In 2025, rapid diagnostic tests (RDTs) are estimated to hold a 54.2% market share due to their portability and quick turnaround time, often delivering results within 30 minutes.

High-burden regions, particularly tribal and forest-based zones in East India, continue to present a steady demand for both RDTs and advanced molecular tools. Hospitals and clinics remain critical in disease surveillance, as they serve as the first point of confirmed diagnosis, directly feeding into the national health system's data streams.

Market Dynamics

Driver - Government Interventions and Technology Innovations Fuel Market Expansion

India's healthcare gaps, especially in rural and tribal areas, are driving the need for scalable and rapid diagnostic solutions. With over 95% of the Indian population residing in malaria-endemic regions, and 80% of cases confined to only 20% of the population in difficult terrains, there is a pressing need for efficient diagnostic outreach. Initiatives in Odisha, including the distribution of 40.49 lakh Long-Lasting Insecticidal Nets and deployment of RDTs, reflect proactive state-led efforts.

Technological innovations, such as the AI-enabled MAIScope microscope, are further augmenting diagnostic capabilities in underserved areas. These tools enable frontline health workers to deliver accurate results, even in settings with limited infrastructure.

Restraint - Diagnostic Gaps in Microscopy Undermine Elimination Goals

While microscopy is traditionally regarded as the gold standard, it faces limitations in detecting low-density infections, especially among asymptomatic individuals and in mixed infections involving P. vivax and P. falciparum. Sensitivity levels of microscopy drop significantly to 42.7% in low-transmission areas such as Meghalaya and Assam, making it unreliable for complete case detection. This diagnostic blind spot delays treatment and enables continued transmission, challenging India's goal of malaria elimination by 2030.

Opportunity - Genomic Surveillance Unlocks Region-Specific Diagnostic Strategies

Next-Generation Sequencing (NGS) is emerging as a game-changer in malaria diagnostics. It enables high-resolution genomic surveillance of Plasmodium strains, revealing patterns of antimalarial drug resistance. For instance, a study using amplicon sequencing of 158 isolates in regions like Rourkela and Chennai revealed distinct regional variations in drug resistance markers, facilitating the formulation of localized treatment protocols.

Organizations like India International Centers of Excellence for Malaria Research (ICEMR) are leading efforts to study parasite genetics and resistance profiles. These capabilities are expected to underpin more targeted diagnostics and therapeutic interventions.

Read Detailed Analysis: https://www.persistencemarketresearch.com/market-research/india-malaria-diagnostics-market.asp

Category-wise Analysis

Technology Insights

In 2025, RDTs are forecasted to dominate the Indian market with a 54.2% share, driven by their compatibility with field conditions and minimal infrastructure requirements. They are indispensable tools in public health efforts across Assam, Jharkhand, and Odisha, where terrain and accessibility are major challenges.

PCR and other molecular diagnostics are projected to record significant growth over the forecast period. These tools are increasingly being adopted in academic and advanced clinical settings for their ability to detect parasitemia as low as 1 parasite per microliter. Their value lies in identifying hidden carriers, particularly in low-endemic zones, where traditional tests often fall short.

End-use Insights

Hospitals and clinics will account for nearly 45.6% of the market in 2025, thanks to their role in handling severe and complicated malaria cases. The widespread use of RDTs in these settings ensures cost-effective, fast diagnostics, aiding in early intervention.

Diagnostic centers are also gaining prominence due to their specialization and capacity to deploy advanced testing technologies. Their ability to service remote areas with accurate testing makes them pivotal to nationwide malaria control efforts.

Regional Insights

East India

States such as Odisha, Jharkhand, Assam, and Meghalaya are at the heart of India's malaria burden. Odisha alone accounted for 42,000 cases in 2023, constituting 18.7% of the national total. Programs like DAMaN have been instrumental in malaria mitigation, particularly by targeting hotspots and ensuring rapid diagnostics.

In the Northeast, studies indicate that nearly 19.5% of individuals screened in Assam and Meghalaya carried the parasite, including asymptomatic carriers. The limitations of microscopy in these regions necessitate broader adoption of high-sensitivity molecular tools.

North India

In states like Punjab and Haryana, malaria incidence has declined sharply. However, the prevalence of submicroscopic infections, as revealed by PCR studies, highlights the shortcomings of traditional methods. Only 49 cases were detected using microscopy, while nested PCR uncovered 64 cases in the same group, underscoring the urgent need for updated diagnostic protocols.

The region also suffers from weak surveillance systems due to poor private sector data integration and a heavy reliance on paper-based reporting.

West India

Malaria diagnostics in West India, covering Maharashtra, Gujarat, and Rajasthan, benefit from a combination of grassroots surveillance and urban infrastructure. Public health programs offer free microscopy, complemented by active surveillance through field agents. However, diagnostic delays have often led to presumptive treatment, fostering drug resistance.

RDT adoption is helping address this issue. For example, studies in Ahmedabad have emphasized the validity and reliability of RDTs as alternatives to conventional blood smears, improving the accuracy and speed of treatment.

Competitive Landscape

India's malaria diagnostics market features a mix of global firms, domestic players, and public-private partnerships. Multinational companies are introducing next-gen diagnostics, leveraging their global R&D strengths to deliver high-accuracy tools suited for Indian conditions.

Local firms, meanwhile, are focusing on cost-efficient diagnostic kits tailored to rural and semi-urban regions. Their deep understanding of local healthcare challenges positions them well to capture market share through affordability and accessibility.

Request for Customization of the Research Report: https://www.persistencemarketresearch.com/request-customization/35426

Key Players

Leading companies in the market include Bio-Rad Laboratories Inc., Access Bio Inc., Abbott India Limited, Hologic, Inc., Roche Diagnostics India Pvt. Ltd., Sysmex India Private Limited, Becton Dickinson India Private Limited, Siemens Healthineers AG, Meridian Bioscience, Olympus Corporation, Nikon India Pvt. Ltd., Beckman Coulter, Inc., MicroGene Diagnostic Systems (P) Ltd, Premier Medical, and BIOMÉRIEUX.

Recent Developments

In April 2025, the National Vector Borne Disease Control Program highlighted Mizoram as having the highest malaria prevalence in India based on API data. Emphasis was placed on SRD (Source Reduction Drive) activities at the village level as critical to malaria elimination efforts.

In May 2024, Serum Institute of India initiated global supply of the R21/Matrix-M malaria vaccine to Africa. This milestone indicates India's expanding role not only in diagnostics but also in global malaria control through vaccine exports.

Market Segmentation

The India malaria diagnostics market is segmented based on technology (Microscopy, RDTs, Molecular Diagnostics), end-use (Hospitals and Clinics, Diagnostic Centers, Academic and Research Institutions), and region (North, South, East, West). RDTs remain the most widely used technology, while hospitals and diagnostic centers are the key end-users.

Future Outlook

From 2025 to 2032, India's malaria diagnostics market will be shaped by a combination of policy intervention, diagnostic innovation, and expanded health system reach. While RDTs will remain vital for mass deployment, molecular tools will gain ground as India transitions toward malaria elimination by 2030.

Investments in genomic surveillance, mobile diagnostics, and AI-powered tools will open new frontiers in targeted detection and treatment. Moreover, the increasing role of private sector labs and diagnostic chains will accelerate the availability of high-quality, affordable diagnostics across geographies.

Read More Related Reports:

Injectable Nanomedicines Market https://www.persistencemarketresearch.com/market-research/injectable-nanomedicines-market.asp
Neurovascular Thrombectomy Devices Market https://www.persistencemarketresearch.com/market-research/neurovascular-thrombectomy-devices-market.asp
Orthopedic Planning System Market https://www.persistencemarketresearch.com/market-research/orthopedic-planning-system-market.asp
Cooling Therapy Devices Market https://www.persistencemarketresearch.com/market-research/cooling-therapy-devices-market.asp
Veterinary Intraocular Lenses Market https://www.persistencemarketresearch.com/market-research/veterinary-intraocular-lenses-market.asp

Contact Us:

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.